• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌术后静脉血栓栓塞症风险评估模型的构建:一项中国单中心研究。

Construction of Risk Assessment Model for Venous Thromboembolism After Colorectal Cancer Surgery: A Chinese Single-Center Study.

机构信息

56660Sir-Run-Run-Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Deqing People's Hospital, Deqing, China.

出版信息

Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211073748. doi: 10.1177/10760296211073748.

DOI:10.1177/10760296211073748
PMID:35167387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851938/
Abstract

OBJECTIVE

A retrospective study was carried out to construct a postoperative venous thromboembolism (VTE) risk assessment model (RAM) applicable for Chinese colorectal cancer patients.

METHODS

541 Patients who underwent colorectal cancer surgery from June 2019 to May 2020 at Sir-Run-Run-Shaw Hospital affiliated to Zhejiang University School of Medicine were enrolled in this study. Multi-factor analysis was used to determine the independent risk factors of VTE. A novel RAM of VTE which we called Sir-Run-Run-Shaw VTE RAM were constructed basing on the independent risk factors. Another study cohort consisted of 287 colorectal cancer patients underwent surgery from January 2021 to June 2021was used for model evaluation.

RESULTS

The incidence of VTE after colorectal cancer surgery was 12.0%(65/541). Among the 65 VTE Patients, DVT accounted for 92.3% (60/65) and DVT + PE accounted for 7.7% (5/65). Multi-factor analysis showed that age ≥ 69 years ( < 0.01), preoperative plasma D-dimer ≥ 0.49 mg/L ( = .004), stage IV of cancer ( = .018) and transfusion ( = .004) are independent risk factors of VTE after surgery. Sir-Run-Run-Shaw VTE RAM includes the above 4 factors, and the total score is 4 points. The score of the low, medium and high risk groups are 0, 1 and ≥2 points. The area under the ROC curve (AUC) of Sir-Run-Run-Shaw VTE RAM is 0.769, while Caprini RAM is 0.656. There is statistical difference between the two risk score tables ( = 2.337,  = .0195).

CONCLUSION

A VTE RAM is constructed basing on a single center retrospective study. This score table may be applicable for Chinese patients with colorectal cancer surgery.

摘要

目的

本研究通过回顾性分析,构建一个适用于中国结直肠癌患者的术后静脉血栓栓塞症(venous thromboembolism,VTE)风险评估模型(risk assessment model,RAM)。

方法

回顾性分析 2019 年 6 月至 2020 年 5 月浙江大学医学院附属邵逸夫医院收治的 541 例行结直肠癌手术患者的临床资料,采用多因素分析确定 VTE 的独立危险因素,基于独立危险因素构建新的 VTE RAM(称为邵逸夫 VTE RAM)。另外一项研究队列纳入 2021 年 1 月至 2021 年 6 月在本院行手术治疗的 287 例结直肠癌患者,用于模型评估。

结果

结直肠癌术后 VTE 发生率为 12.0%(65/541)。65 例 VTE 患者中,深静脉血栓(deep vein thrombosis,DVT)占 92.3%(60/65),DVT 合并肺栓塞(pulmonary embolism,PE)占 7.7%(5/65)。多因素分析显示,年龄≥69 岁(<0.01)、术前血浆 D-二聚体≥0.49mg/L(=0.004)、肿瘤分期为Ⅳ期(=0.018)和输血(=0.004)是术后 VTE 的独立危险因素。邵逸夫 VTE RAM 包括上述 4 个因素,总分 4 分,低、中、高危组的评分分别为 0、1 和≥2 分。邵逸夫 VTE RAM 的 ROC 曲线下面积(area under the ROC curve,AUC)为 0.769,Caprini RAM 为 0.656,两者差异有统计学意义(=2.337,=0.0195)。

结论

本研究基于单中心回顾性研究构建了 VTE RAM,该评分表可能适用于中国结直肠癌手术患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/899a/8851938/ade80e048c91/10.1177_10760296211073748-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/899a/8851938/ade80e048c91/10.1177_10760296211073748-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/899a/8851938/ade80e048c91/10.1177_10760296211073748-fig1.jpg

相似文献

1
Construction of Risk Assessment Model for Venous Thromboembolism After Colorectal Cancer Surgery: A Chinese Single-Center Study.结直肠癌术后静脉血栓栓塞症风险评估模型的构建:一项中国单中心研究。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211073748. doi: 10.1177/10760296211073748.
2
Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.术后D-二聚体可预测接受泌尿外科肿瘤手术患者的静脉血栓栓塞。
Urol Oncol. 2018 Jun;36(6):307.e15-307.e21. doi: 10.1016/j.urolonc.2018.03.003. Epub 2018 Mar 26.
3
Incidence, prevention, risk factors, and prediction of venous thromboembolism in Chinese patients after colorectal cancer surgery: a prospective, multicenter cohort study.中国结直肠癌术后患者静脉血栓栓塞症的发生率、预防、危险因素及预测:一项前瞻性、多中心队列研究。
Int J Surg. 2023 Oct 1;109(10):3003-3012. doi: 10.1097/JS9.0000000000000553.
4
Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.比较 Khorana 预测评分和 Caprini 风险评估模型在评估住院癌症患者静脉血栓栓塞风险中的应用:一项回顾性病例对照研究。
Interact Cardiovasc Thorac Surg. 2020 Oct 1;31(4):454-460. doi: 10.1093/icvts/ivaa137.
5
Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.Caprini风险评估模型及肿瘤特异性D-二聚体水平升高在预测妇科恶性肿瘤手术患者术后静脉血栓栓塞中的应用价值
J Obstet Gynaecol Res. 2019 Mar;45(3):657-664. doi: 10.1111/jog.13832. Epub 2018 Nov 4.
6
Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care.入住重症监护病房接受术后护理的癌症患者静脉血栓栓塞的发病率及风险评估
J BUON. 2018 Jan-Feb;23(1):500-506.
7
Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative care.入住重症监护病房接受术后护理的癌症患者静脉血栓栓塞的发生率及风险评估
J BUON. 2018 Jan-Feb;23(1):248-254.
8
Clinical analysis of postoperative venous thromboembolism in Japanese patients after colorectal cancer surgery.日本结直肠癌术后患者术后静脉血栓栓塞的临床分析。
Surg Today. 2021 Jun;51(6):1022-1027. doi: 10.1007/s00595-020-02201-5. Epub 2021 Jan 2.
9
Efficacy of Caprini risk assessment model in predicting venous thromboembolism risks among Asian surgical patients.卡普里风险评估模型在预测亚洲外科手术患者静脉血栓栓塞风险中的疗效。
Med J Malaysia. 2024 May;79(3):320-325.
10
Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer.Caprini 评分联合血栓动力检测可减少结直肠癌患者术后未预测到的静脉血栓栓塞事件的发生。
J Vasc Surg Venous Lymphat Disord. 2020 Jan;8(1):31-41. doi: 10.1016/j.jvsv.2019.06.015. Epub 2019 Sep 5.

引用本文的文献

1
Effectiveness and Safety of Long-Term Venous Thromboembolism Prophylaxis After Colorectal Cancer Surgery: A Retrospective Study.结直肠癌手术后长期静脉血栓栓塞预防的有效性和安全性:一项回顾性研究
Drugs Real World Outcomes. 2025 Aug 5. doi: 10.1007/s40801-025-00510-0.
2
Risk Factors of Venous Thromboembolism in Inpatients With Colorectal Cancer in China.中国结直肠癌住院患者静脉血栓栓塞症的危险因素。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231221133. doi: 10.1177/10760296231221133.
3
Establishment and Validation of a Postoperative VTE Prediction Model in Patients with Colorectal Cancer Undergoing Radical Resection: CRSPOT Nomogram.

本文引用的文献

1
High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.高血浆可溶性 P 选择素和因子 VIII 水平可预测非小细胞肺癌患者的静脉血栓栓塞:血栓-Nsclc 风险评分。
Thromb Res. 2020 Dec;196:349-354. doi: 10.1016/j.thromres.2020.09.021. Epub 2020 Sep 16.
2
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.美国血液学会 2019 年静脉血栓栓塞症管理指南:手术住院患者静脉血栓栓塞症的预防。
Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975.
3
结直肠癌根治术后患者静脉血栓栓塞症预测模型的建立与验证:CRSPOT 列线图。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231216966. doi: 10.1177/10760296231216966.
4
Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study.用于预测结直肠癌住院患者术后静脉血栓栓塞的机器学习模型的开发与验证:一项回顾性研究。
J Gastrointest Oncol. 2023 Feb 28;14(1):220-232. doi: 10.21037/jgo-23-18. Epub 2023 Feb 15.
5
Derivation and External Validation of a Risk Assessment Model of Venous Thromboembolism in Hospitalized Chinese Patients.中文译文:住院中国患者静脉血栓栓塞风险评估模型的推导和外部验证。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296221151164. doi: 10.1177/10760296221151164.
6
Risk factors and potential predictors of pulmonary embolism in cancer patients undergoing thoracic and abdominopelvic surgery: a case control study.接受胸腹部和盆腔手术的癌症患者发生肺栓塞的危险因素及潜在预测因素:一项病例对照研究
Thromb J. 2022 Dec 22;20(1):80. doi: 10.1186/s12959-022-00442-7.
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).
2019年欧洲心脏病学会(ESC)与欧洲呼吸学会(ERS)合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
4
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.2019 年国际癌症患者静脉血栓栓塞症治疗和预防临床实践指南。
Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3.
5
Pre-Operative, Intra-Operative, and Post-Operative Factors Associated with Post-Discharge Venous Thromboembolism Following Colorectal Cancer Resection.术前、术中及术后因素与结直肠癌切除术后出院后静脉血栓栓塞的关系。
J Gastrointest Surg. 2020 Jan;24(1):144-154. doi: 10.1007/s11605-019-04354-2. Epub 2019 Aug 16.
6
Current status of venous thromboembolism development during the perioperative period for colorectal cancer, its prevention with enoxaparin, and monitoring methods.结直肠癌围手术期静脉血栓栓塞症的发生现状、依诺肝素对其的预防及监测方法
Ther Clin Risk Manag. 2019 Jun 21;15:791-802. doi: 10.2147/TCRM.S201954. eCollection 2019.
7
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.静脉血栓栓塞症预防和治疗癌症患者:ASCO 临床实践指南更新。
J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 2019 Aug 5.
8
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.直接口服抗凝剂在门诊癌症患者一级血栓预防中的应用:国际血栓与止血学会科学与标准化委员会的指南
J Thromb Haemost. 2019 Oct;17(10):1772-1778. doi: 10.1111/jth.14564. Epub 2019 Jul 28.
9
A novel risk assessment model for venous thromboembolism after major thoracic surgery: a Chinese single-center study.一种用于重大胸外科手术后静脉血栓栓塞的新型风险评估模型:一项中国单中心研究。
J Thorac Dis. 2019 May;11(5):1903-1910. doi: 10.21037/jtd.2019.05.11.
10
Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study.专科姑息治疗病房中晚期癌症患者深静脉血栓形成的患病率、症状负担及自然史(HIDDen):一项前瞻性纵向观察研究
Lancet Haematol. 2019 Feb;6(2):e79-e88. doi: 10.1016/S2352-3026(18)30215-1.